A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)

NCT06594679 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Niraparib Tosylate Monohydrate

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Collaborators

[object Object]
[object Object]